FIG. 9.
Summary of multilineage eGFP expression levels determined in peripheral blood, bone marrow, thymus, and spleen harvested from NSG mice 5 months after neonatal transplantation of HSB-modified human CD34+ cells. Shown is the percentage of human CD45+eGFP+ cells detected in CD4+ or CD8+ T cells, CD19+ B cells, CD56+ NK cells, and CD14+ myeloid cells from all organs harvested from (A) NSG mouse C-2 and (B) NSG mouse D-5.